Our findings demonstrate the complexity of cancer care in custodial settings, identifying barriers and enablers to equitable ...

Olivia Munn is living with a new normal after undergoing a double mastectomy and entering medically induced menopause last ...

Targeted therapies and immunotherapies across the ovarian, endometrial, and cervical cancers landscape play expanded roles, ...

AstraZeneca and Daiichi Sankyo's Enhertu, a HER2-directed antibody drug conjugate (ADC), has demonstrated significant ...

King Charles III on Tuesday makes his first official public appearance since being diagnosed with cancer, after doctors said ...

(UroToday.com) The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) held in Lugano, Switzerland between April 25 th ...

Recommend PSMA radioligand therapy before chemotherapy for patients who (i) meet imaging criteria for PSMA radioligand ...

metastatic or recurrent biliary tract cancer (N=24). Findings showed an overall response rate (ORR) of 37.5% (95% CI, 18.8-59.4). Median duration of response and progression free survival were 9.4 ...

During a Case-Based Roundtable® event, Hope S. Rugo, MD, FASCO, moderated a discussion on treatment options for a patient ...

Seeking more data on adjuvant alectinib in patients who have resectable ALK-positive non–small cell lung cancer (NSCLC), ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced the European Commission (EC) has approved a label extension for XTANDI™ (enzalutamide) as monotherapy or ...

AI tools like ChatGPT “have real potential,” but more research is needed to assess their accuracy on medical topics, according to Benjamin J. Matthews, MD. ChatGPT can often answer patient questions ...